Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies -study – Reuters

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies -study – Reuters

Regeneron Pharmaceuticals Inc’s (REGN.O) COVID-19 antibody cocktail reduces deaths in hospitalised patients who have not mounted their own antibody response, a large British study published on Wednesday found.

Read More…

You May Also Like